Special Issue "Fungal Pathogens: Resistance and Novel Therapeutics"
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (30 June 2020) | Viewed by 21772
Interests: Candida auris; polymicrobial infections; biofilms; decontamination; antifungal resistance
Fungal infections play a surprising yet unrecognised health burden on the global population, with diseases ranging from superficial infections to life-threatening bloodstream infections. Most pathogenic fungi are regarded as opportunistic, capable of causing debilitating disease in immunocompromised individuals and are commonly associated with unacceptability high mortality rates, accounting for ~1.6 million deaths each year. The success of fungal pathogenesis can be attributed to several factors, including the ability of these organisms to adapt to their environment and resist antifungal therapy. In a climate where antimicrobial resistance continues to increase and the rate of new drug discovery slows, coupled with the unprecedented emergence of new fungal pathogens such as Candida auris, it is of paramount interest to fully understand the underlying mechanisms of resistance and use these findings to translate and identify alternative strategies for the management of fungal infections.
This special issue welcomes original research and review articles and aims to collate the most recent findings on antifungal resistance and highlight potential novel therapeutics for the clinical management of these infections.
Dr. Ryan Kean
Dr. Leighann Sherry
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Pathogenic fungi
- novel agents